Investors locked out of trading sites as they scramble to capitalise on Pfizer’s vaccine announcement By Fiona Parker For The Daily Mail Published: 21:55 GMT, 9 November 2020 | Updated: 21:55 GMT, 9 November 2020 Investors were yesterday locked out of some of Britain’s largest trading platforms as they rushed to capitalise on Pfizer’s vaccine … Read more
Donald Trump Jr. has cast suspicion over the timing of Pfizer’s COVID-19 vaccine ‘breakthrough’ which was announced on Monday two days after the election was called for Biden. Pfizer revealed on Monday that its vaccine was 90 percent effective among study participants and that it would produce 1.3billion doses – enough to treat 650million people … Read more
‘Summer 2021 is going to be the party to end all parties!’ Britons take to social media in hope their lives could be back to normal by next year as experts hail Pfizer Covid vaccine UK has ordered 40million doses of the jab – enough to cover 20m people Boris Johnson is due to hold … Read more
‘Summer 2021 is going to be the party to end all parties!’ Britons take to social media in hope their lives could be back to normal by next year as experts hail Pfizer Covid vaccine UK has ordered 40million doses of the jab – enough to cover 20m people Boris Johnson is due to hold … Read more
US biotech firm Moderna, one of nine companies in the late stages of clinical trials for a Covid-19 vaccine, became the first to publish the complete blueprints of its study following calls for greater transparency. Pfizer, the other American company currently carrying out Phase 3 trials in the US, followed suit a short time later … Read more
Pfizer Inc says it could have results from its late-stage coronavirus vaccine trial available as early as October. On Thursday, CEO Albert Bourla said during a call sponsored by drug industry group International Federation of Pharmaceutical Manufacturers & Associations that 23,000 volunteers have been enrolled in the phase III trial, which began in July. The … Read more
Pfizer Inc signs multi-year deal to manufacture Gilead’s coronavirus antiviral remdesivir to boost production of the drug Pfizer Inc has signed a multi-year deal with Gilead Sciences Inc to manufacture and supply the antiviral remdesivir The drug is the only one approved in the US to treat coronavirus patients by emergency use after it was … Read more
German biotech BioNTech and US drugmaker Pfizer said on Monday they are launching a pivotal global study to evaluate their lead COVID-19 vaccine candidate. If the study is successful, the companies could submit the vaccine for regulatory approval as early as October, putting them on track to supply up to 100 million doses by the … Read more
Britain has signed deals with two foreign pharmaceutical giants for 90million doses of new coronavirus vaccines with the option of buying 40million more, it was revealed today. Agreement has been reached for 30million doses from BioNTech and German firm Pfizer and 60million doses from France’s Valneva. The figure of 90million is in addition to the 100million … Read more